Table 3.
Illness requiring hospitalization that is likely to preclude further study participation. |
Known side-effects of the trial drug which are considered intolerable by the participant. |
Extreme electrolyte disturbances or renal dysfunction. |
Hypotension—If the patient has symptoms consistent with hypotension and clinic systolic BP is <110 mm Hg or the change in BP from previous reading is >30 mm Hg, and in the opinion of the investigator there is no self-limiting reason for hypotension (e.g., episode of dehydration, climatic conditions). |
Abbreviation: BP, blood pressure.